141 related articles for article (PubMed ID: 19752617)
1. De novo urothelial carcinoma in kidney transplantation patients with end-stage aristolochic acid nephropathy in China.
Li HZ; Xia M; Han Y; Xu XG; Zhang YS
Urol Int; 2009; 83(2):200-5. PubMed ID: 19752617
[TBL] [Abstract][Full Text] [Related]
2. De novo urothelial carcinoma in kidney transplant patients with end-stage aristolochic acid nephropathy in China.
Yuan M; Shi YB; Li ZH; Xia M; Ji GZ; Xu GX; Han Y
Transplant Proc; 2009 Jun; 41(5):1619-23. PubMed ID: 19545692
[TBL] [Abstract][Full Text] [Related]
3. Renal transplantation in patients with Balkan endemic nephropathy.
Basic-Jukic N; Hrsak-Puljic I; Kes P; Bubic-Filipi L; Pasini J; Hudolin T; Kastelan Z; Reiner Z; Kordic M; Brunetta B; Juric I
Transplant Proc; 2007 Jun; 39(5):1432-5. PubMed ID: 17580155
[TBL] [Abstract][Full Text] [Related]
4. Transitional cell carcinoma in renal transplant recipients: a single center experience.
Li XB; Xing NZ; Wang Y; Hu XP; Yin H; Zhang XD
Int J Urol; 2008 Jan; 15(1):53-7. PubMed ID: 18184173
[TBL] [Abstract][Full Text] [Related]
5. Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: a case series with 15-year follow-up.
Lemy A; Wissing KM; Rorive S; Zlotta A; Roumeguere T; Muniz Martinez MC; Decaestecker C; Salmon I; Abramowicz D; Vanherweghem JL; Nortier J
Am J Kidney Dis; 2008 Mar; 51(3):471-7. PubMed ID: 18295063
[TBL] [Abstract][Full Text] [Related]
6. Renal cell carcinoma of native kidney in renal transplant recipients.
Moudouni SM; Lakmichi A; Tligui M; Rafii A; Tchala K; Haab F; Gattegno B; Thibault P; Doublet JD
BJU Int; 2006 Aug; 98(2):298-302. PubMed ID: 16879668
[TBL] [Abstract][Full Text] [Related]
7. [De novo urological neoplasms in kidney transplant patients: experience in 1,751 patients].
di Capua Sacoto C; Luján Marco S; Bahilo Mateu P; Budía Alba A; Pontones Moreno JL; Jiménez Cruz JF
Actas Urol Esp; 2010 Jan; 34(1):88-94. PubMed ID: 20223138
[TBL] [Abstract][Full Text] [Related]
8. De novo renal cell carcinoma of native kidney in renal transplant recipients.
Neuzillet Y; Lay F; Luccioni A; Daniel L; Berland Y; Coulange C; Lechevallier E
Cancer; 2005 Jan; 103(2):251-7. PubMed ID: 15593084
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of female non-muscle-invasive bladder cancer in Taiwan: association with upper tract urothelial carcinoma and end-stage renal disease.
Chen CH; Shun CT; Huang KH; Huang CY; Yu HJ; Pu YS
Urology; 2008 Jun; 71(6):1155-60. PubMed ID: 18372011
[TBL] [Abstract][Full Text] [Related]
10. De novo malignancies after kidney transplantation.
Hung YM; Chou KJ; Hung SY; Chung HM; Chang JC
Urology; 2007 Jun; 69(6):1041-4. PubMed ID: 17572182
[TBL] [Abstract][Full Text] [Related]
11. Urothelial cancer in patients with Endemic Balkan Nephropathy (EN) after renal transplantation.
Zivcić-Cosić S; Grzetić M; Valencić M; Oguić R; Maricić A; Dordević G; Balen S; Orlić L; Racki S; Fuckar Z
Ren Fail; 2007; 29(7):861-5. PubMed ID: 17994456
[TBL] [Abstract][Full Text] [Related]
12. Long-term Outcome of Kidney Recipients Transplanted for Aristolochic Acid Nephropathy.
Kanaan N; Hassoun Z; Raggi C; Jadoul M; Mourad M; De Meyer M; Aydin S; Schmeiser HH; Cosyns JP; Goffin E
Transplantation; 2016 Feb; 100(2):416-21. PubMed ID: 26457602
[TBL] [Abstract][Full Text] [Related]
13. Different treatment strategies for end stage renal disease in patients with transitional cell carcinoma.
Wu CF; Shee JJ; Ho DR; Chen WC; Chen CS
J Urol; 2004 Jan; 171(1):126-9. PubMed ID: 14665859
[TBL] [Abstract][Full Text] [Related]
14. The outcome of patients on dialysis with upper urinary tract transitional cell carcinoma.
Wu CF; Chang PL; Chen CS; Chuang CK; Weng HH; Pang ST
J Urol; 2006 Aug; 176(2):477-81. PubMed ID: 16813872
[TBL] [Abstract][Full Text] [Related]
15. A retrospective review of patients with urothelial cancer in 3,370 recipients after renal transplantation: a single-center experience.
Zhang A; Shang D; Zhang J; Zhang L; Shi R; Fu F; Tian Y
World J Urol; 2015 May; 33(5):713-7. PubMed ID: 25239501
[TBL] [Abstract][Full Text] [Related]
16. CKD as a risk factor for bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma.
Chung SD; Huang KH; Lai MK; Huang CY; Chen CH; Pu YS; Yu HJ; Chueh SC
Am J Kidney Dis; 2007 Nov; 50(5):743-53. PubMed ID: 17954287
[TBL] [Abstract][Full Text] [Related]
17. Urological malignancy as a complication of renal transplantation: a report of twelve clinical cases.
Zhou M; Zhu Y; Wang L; Wang Y; Fu S; Min Z
Clin Transpl; 2006; ():395-8. PubMed ID: 18365395
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic management of de novo urological malignancy in renal transplant recipients: the experience of the French Department of Urology and Kidney Transplantation from Bordeaux.
Elkentaoui H; Robert G; Pasticier G; Bernhard JC; Couzi L; Merville P; Ravaud A; Ballanger P; Ferrière JM; Wallerand H
Urology; 2010 Jan; 75(1):126-32. PubMed ID: 19864001
[TBL] [Abstract][Full Text] [Related]
19. Risks of kidney failure associated with consumption of herbal products containing Mu Tong or Fangchi: a population-based case-control study.
Lai MN; Lai JN; Chen PC; Hsieh SC; Hu FC; Wang JD
Am J Kidney Dis; 2010 Mar; 55(3):507-18. PubMed ID: 20116155
[TBL] [Abstract][Full Text] [Related]
20. Early de novo malignancies after kidney transplantation.
Veroux M; Puliatti C; Fiamingo P; Cappello D; Macarone M; Puliatti D; Vizcarra D; Gagliano M; Veroux P
Transplant Proc; 2004 Apr; 36(3):718-20. PubMed ID: 15110643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
